Medicare Enrolled

Dr. Titu Das, MD

Infectious Disease · Roswell, GA
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
11660 ALPHARETTA HWY, Roswell, GA 30076
7702551069
In practice since 2005 (20 years)
NPI: 1831188085 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Das from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Das? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Das

Dr. Titu Das is an infectious disease specialist in Roswell, GA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Das performed 162,003 Medicare services across 877 unique beneficiaries.

Between the years covered by Open Payments, Dr. Das received a total of $5,375 from 40 pharmaceutical and/or device companies across 258 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in infectious disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Das is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 4% volume in GA $5,375 industry payments

Medicare Practice Summary

Medicare Utilization ↗
162,003
Medicare services
Top 4% in GA for infectious disease
877
Unique beneficiaries
$1
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~8,100 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Daptomycin antibiotic injection 154,254 $0 $0
Ceftriaxone antibiotic injection
This code represents the administration of ceftriaxone sodium, an antibiotic medication. The charge is calculated for every 250 mg of the drug administered.
3,328 $0 $1
Intravenous infusion, 1 hour or less
Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less.
1,327 $51 $144
Ertapenem sodium injection, 500 mg
An injection of ertapenem sodium, an antibiotic medication, administered at a dose of 500 mg.
806 $11 $26
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
523 $98 $231
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
428 $61 $158
Additional sequential IV infusion, 1 hour or less
This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less.
340 $23 $63
Blood draw (venipuncture)
Insertion of a needle into a vein to collect a blood sample.
242 $8 $13
Initial hospital admission, moderate complexity
Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter.
163 $100 $292
Intravenous injection of additional new drug or substance
Administration of an additional new medication or substance directly into a vein.
149 $12 $31
Normal saline infusion, 250 cc
Administration of 250 cubic centimeters of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater fluid.
148 $1 $1
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
88 $11 $35
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
64 $132 $333
Hospital follow-up visit, high complexity
Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter.
51 $95 $220
Wound tissue removal, 20 sq cm or less
This procedure involves the removal of tissue from a wound area measuring 20 square centimeters or less.
39 $80 $198
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
39 $65 $152
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
14 $139 $443
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
1.1% high complexity
97.9% medium
1.0% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$5,375
Total received (2018-2024)
Avg $768/year across 7 years
Top 28% in GA for infectious disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
40
Companies
258
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,295 (98.5%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$80 (1.5%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,124
2023
$168
2022
$671
2021
$1,667
2020
$889
2019
$640
2018
$215

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Paratek Pharmaceuticals, Inc.
$254
Merck Sharp & Dohme LLC
$197
Gilead Sciences, Inc.
$122
ViiV Healthcare Company
$100
Astellas Pharma US Inc
$80
Melinta Therapeutics, LLC
$69
Insmed, Inc.
$68
Kerecis Limited
$60
Ferring Pharmaceuticals Inc.
$45
PFIZER INC.
$45
ABBVIE INC.
$32
Takeda Pharmaceuticals U.S.A., Inc.
$26
Grifols USA, LLC
$26
Top 3 companies account for 50.9% of 2024 payments
All-time payments by company (2018-2024) ›
Paratek Pharmaceuticals, Inc.
$966
CIPLA USA INC.
$631
ViiV Healthcare Company
$585
Gilead Sciences, Inc.
$481
Insmed, Inc.
$337
Merck Sharp & Dohme Corporation
$288
Merck Sharp & Dohme LLC
$235
Melinta Therapeutics, LLC
$208
AbbVie Inc.
$159
Melinta Therapeutics, Inc.
$154
PFIZER INC.
$146
MAYNE PHARMA INC.
$119
Kerecis Limited
$115
La Jolla Pharmaceutical Company
$107
Astellas Pharma US Inc
$99
TETRAPHASE PHARMACEUTICALS, INC.
$64
Organogenesis Inc.
$63
Allergan, Inc.
$56
Mylan Pharmaceuticals Inc.
$46
Ferring Pharmaceuticals Inc.
$45
Smith+Nephew, Inc.
$42
Shionogi Inc
$41
Medline Industries, Inc.
$39
ABBVIE INC.
$32
Takeda Pharmaceuticals U.S.A., Inc.
$26
Grifols USA, LLC
$26
Lundbeck LLC
$24
GENZYME CORPORATION
$24
Amgen Inc.
$23
3M Company
$22
KCI USA, Inc.
$22
Janssen Biotech, Inc.
$22
Shire North American Group Inc
$20
Teva Pharmaceuticals USA, Inc.
$18
Theravance Biopharma, Inc.
$18
Cumberland Pharmaceuticals, Inc.
$17
Allergan Inc.
$15
Smith & Nephew, Inc.
$14
SANOFI PASTEUR INC.
$14
Genentech USA, Inc.
$14
Top 3 companies account for 40.6% of all-time payments
Associated products mentioned in payments ›
APRETUDE · AVSOLA · AVYCAZ · Apligraf · Arikayce · Baxdela · BlastX Wound Gel · CABENUVA · CAPVAXIVE · CRESEMBA · CUVITRU · DALVANCE · DIFICID · DORYX · DOVATO · Descovy · FLUBLOK QUADRIVALENT · Fetroja · GATTEX · Hyalomatrix Wound Device · ISENTRESS · Kerecis Omega3 SurgiClose · Kerecis Omega3 Wound · Kimyrsa · LEMTRADA · NUZYRA · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · Orbactiv · PANZYGA · PICO Single Use Negative Pressure Wound Therapy · PICO7 · PIFELTRO · PREVNAR 13 · PluroGel Burn and Wound Dressings · ProAir Digihaler · Puraply · REBYOTA · RUKOBIA · Rezzayo · SNAP · SYMTUZA · Santyl · Symfi Lo · Truvada · VIBATIV · VYEPTI · Vabomere · XERAVA · Xembify · Xerava · ZEMDRI (PLAZOMICIN) · ZERBAXA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for an infectious disease specialist in Roswell?
Compare infectious diseases in the Roswell area by procedure volume, costs, and industry payment transparency.
Browse infectious diseases nearby

Geographic Context

Infectious diseases within 10 mi
196
Per 100K population
18.3
County median income
$91,490
Nearest hospital
WELLSTAR NORTH FULTON MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Das is a mixed practice specialist, with above-average Medicare volume (top 4% in GA), with low-engagement industry engagement, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Das experienced with daptomycin antibiotic injection?
Based on Medicare claims data, Dr. Das performed 154,254 daptomycin antibiotic injection services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Das receive payments from pharmaceutical companies?
Yes. Dr. Das received a total of $5,375 from 40 companies across 258 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Das's costs compare to other infectious diseases in Roswell?
Dr. Das's average Medicare payment per service is $1. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Das) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →